Drugmakers including Pfizer Inc , GlaxoSmithKline PLC , Bristol Myers Squibb , AstraZeneca PLC and Sanofi SA plan to raise prices in the United States on more than 350 unique drugs in early January, according to data analyzed by healthcare research firm 3 Axis Advisors.
plan to raise prices in the United States on more than 350 unique drugs in early January, according to data analyzed by healthcare research firm 3 Axis Advisors.
In 2022, drugmakers raised prices on more than 1,400 drugs according to data published by 46brooklyn, a drug pricing non-profit that is related to 3 Axis. That is the most increases since 2015. Antonio Ciaccia, president of 3 Axis, said that drugmakers have focused on launching their drugs at higher prices because of the attention paid to annual price increases. The IRA should further this dynamic, he said.
To date, Pfizer announced the most increases, with prices rising on 89 unique drug brands, and an additional increase on 10 drug brands at its Hospira arm. A company spokesperson said there were several driving factors in increasing the list price of the two CAR-T cell therapies, including the rate of inflation, the value of the therapies, and the personalized nature of the CAR-T manufacturing process.
Pfizer noted that net prices - those the company actually receives for its drugs - have fallen in the past four years because of higher rebates and discounts paid to insurance companies and pharmacy benefit managers.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Pharma industry to hike prices on over 350 drugs in USDrugmakers including Pfizer, GlaxoSmithKline, Bristol Myers Squibb, AstraZeneca and Sanofi plan to raise prices in US on more than 350 unique drugs
Leer más »
Pharma Giants to Hike 350+ US Drug Prices in the New Year: AnalysisResponding to a report that BigPharma will hike prices on over 350 drugs next week, actdottv said: 'Why? Because they can. Big Pharma does not care about us.'
Leer más »
January 6 committee withdraws subpoena of former President Donald Trump'In light of the imminent end of our investigation, the Select Committee can no longer pursue the specific information covered by the subpoena,' Chairman Bennie Thompson said.
Leer más »
January 6 committee withdraws subpoena of former President Donald Trump'In light of the imminent end of our investigation, the Select Committee can no longer pursue the specific information covered by the subpoena,' Chairman Bennie Thompson said.
Leer más »
January 6 committee withdraws subpoena of former President Donald Trump'In light of the imminent end of our investigation, the Select Committee can no longer pursue the specific information covered by the subpoena,' Chairman Bennie Thompson said.
Leer más »